Nutra Pharma and University of Maryland Bioprocess Scale-Up Facility for Phase II Studies
Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing...
Recro Pharma Presents Phase III Bunionectomy Clinical Data For IV Meloxicam
Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings announced the presentation of...
Lexicon pharmaceuticals reports phase3 study for sotagliflozin in patients with type 1 diabetes
Lexicon Pharmaceuticals announced additional positive data from the Phase 3 inTandem1 study. ...
Milestone Pharma Announces Etripamil Phase 2 Clinical Program Success for the Treatment of PSVT
Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular compan announced positive data from its Phase 2 NODE-1 trial evaluating etripamil, a novel, potent,...
Poxel Announces Positive Top Line Results for Imeglimin Phase 2b Study for Type 2 Diabetes
POXEL SA , a biopharmaceutical company focused on the development of innovative drugs to treat metabolic diseases, including type 2 diabetes, announced today positive...
Chugai’s phase III ALEX study comparing Alecensa and crizotinib meets primary endpoint
Chugai Pharmaceutical Co., Ltd. announced that Alecensa as an initial (first-line) treatment showed that patients lived significantly longer without disease worsening (progression-free survival, PFS)...
Kyowa Hakko Kirin Announces Positive Results of the Phase 3 Clinical Study of Mogamulizumab (KW-0761)
Kyowa Hakko Kirin Co., Ltd. announced the Global Phase 3 study (MAVORIC: Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use of mogamulizumab (KW-0761)...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...
